Stockreport

NICE Enables Access to First Treatment That Targets the Underlying Pathophysiology of Rare Disease X-Linked Hypophosphataemia (XLH) in Adults1 [Yahoo! Finance]

KIRIN HLDGS CO LTD S/ADR  (KNBWY) 
US:NASDAQ Investor Relations: kirinholdings.co.jp/english/ir
PDF treatment of adults living with X-linked hypophosphataemia (XLH) in England, Wales and Northern Ireland LONDON, June 21, 2024 BUSINESS WIRE )--Adults living with the r [Read more]